Osavampator
Chemical compound
Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.).
Nº Q116977443 ★
Comum · Saberes
Osavampator
Chemical compound
Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.).
Na Wikipédia
Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.
Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.). Takeda Pharmaceuticals discovered the molecule originally, and holds exclusive right to market the drug in Japan, while Neurocrine Biosciences holds the right to market it to the rest of the world.
Texto: Wikipédia em inglês, CC BY-SA 4.0. · Imagem: User:Innerstream (Public domain) ·
Cartas próximas
-
Coluracetam
Chemical compound
Nº Q3683872 ★
Sem ofertas
-
Ipidacrine
Chemical compound
Nº Q15409425 ★
Sem ofertas
-
Seltorexant
Chemical compound
Nº Q27273944 ★
Sem ofertas
-
Clomipramina
Composto químico
Nº Q58713 ★★★
Sem ofertas
-
Tiagabina
Composto químico
Nº Q907219 ★
Sem ofertas
-
Inibidor de recaptação de serotonina e noradrenalina
Nº Q2273909 ★★★
Sem ofertas